MT10109L in the Treatment of Glabellar Lines (GL) With or Without Concurrent Treatment of Lateral Canthal Lines (LCL)
Clinical trial NCT03721016 · COMPLETED
Trial details
- NCT number
- NCT03721016
- Sponsor
- Medy-Tox
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-26
- Primary completion
- 2020-03-05
- Enrollment
- 415
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.